Cargando…
A Review on Currently Available Potential Therapeutic Options for COVID-19
A series of unexplained pneumonia cases currently were first reported in December 2019 in Wuhan, China. Official names have been announced for the virus responsible, previously known as “2019 novel coronavirus” and the diseases it causes are, severe acute respiratory syndrome coronavirus 2 (SARS-CoV...
Autor principal: | Ohadian Moghadam, Solmaz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7387864/ https://www.ncbi.nlm.nih.gov/pubmed/32801840 http://dx.doi.org/10.2147/IJGM.S263666 |
Ejemplares similares
-
Potential therapeutic options for COVID-19: an update on current evidence
por: Niknam, Zahra, et al.
Publicado: (2022) -
Autolysin (lytA) recombinant protein: a potential target for developing vaccines against pneumococcal infections
por: Afshar, Davoud, et al.
Publicado: (2020) -
Potential Therapeutic Options for COVID-19
por: Zheng, Xiaoqin, et al.
Publicado: (2020) -
The current understanding and potential therapeutic options to combat COVID-19
por: Pooladanda, Venkatesh, et al.
Publicado: (2020) -
The Detection of Mupirocin Resistance and Nasal Carriage of Methicillin Resistant Staphylococcus aureus among Healthcare Workers at University Hospitals of Tehran, Iran
por: OHADIAN MOGHADAM, Solmaz, et al.
Publicado: (2015)